287 related articles for article (PubMed ID: 30112996)
1. N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.
Liu X; Dong S; Ma Y; Xu H; Zhao H; Gao Q
Med Chem; 2019; 15(2):196-206. PubMed ID: 30112996
[TBL] [Abstract][Full Text] [Related]
2. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
[TBL] [Abstract][Full Text] [Related]
3. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
[TBL] [Abstract][Full Text] [Related]
4. Bioassay Guided Isolation and Docking Studies of a Potential β-Lactamase Inhibitor from
Elfaky MA; El-Halawany AM; Koshak AE; Alshali KZ; El-Araby ME; Khayat MT; Abdallah HM
Molecules; 2020 May; 25(11):. PubMed ID: 32486455
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
Faheem M; Rehman MT; Danishuddin M; Khan AU
PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
[TBL] [Abstract][Full Text] [Related]
6. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
[TBL] [Abstract][Full Text] [Related]
7. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
[TBL] [Abstract][Full Text] [Related]
8. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
[TBL] [Abstract][Full Text] [Related]
9. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
11. Management of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: current evidence and future prospects.
Sheu CC; Lin SY; Chang YT; Lee CY; Chen YH; Hsueh PR
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):205-218. PubMed ID: 29402125
[TBL] [Abstract][Full Text] [Related]
12. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
Gavara L; Legru A; Verdirosa F; Sevaille L; Nauton L; Corsica G; Mercuri PS; Sannio F; Feller G; Coulon R; De Luca F; Cerboni G; Tanfoni S; Chelini G; Galleni M; Docquier JD; Hernandez JF
Bioorg Chem; 2021 Aug; 113():105024. PubMed ID: 34116340
[TBL] [Abstract][Full Text] [Related]
13. Discovery of
Davies DT; Leiris S; Zalacain M; Sprynski N; Castandet J; Bousquet J; Lozano C; Llanos A; Alibaud L; Vasa S; Pattipati R; Valige R; Kummari B; Pothukanuri S; De Piano C; Morrissey I; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Tassone G; Mangani S; Docquier JD; Pallin D; Elliot R; Lemonnier M; Everett M
J Med Chem; 2020 Dec; 63(24):15802-15820. PubMed ID: 33306385
[TBL] [Abstract][Full Text] [Related]
14. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
Davies DT; Everett M
Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
[TBL] [Abstract][Full Text] [Related]
15. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli.
Rasool U; S P; Parveen A; Sah SK; S H
BMC Complement Altern Med; 2018 Sep; 18(1):244. PubMed ID: 30176904
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
[TBL] [Abstract][Full Text] [Related]
18. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
19. Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.
Danishuddin M; Khan A; Faheem M; Kalaiarasan P; Hassan Baig M; Subbarao N; Khan AU
J Biomol Struct Dyn; 2014; 32(5):741-50. PubMed ID: 23600675
[TBL] [Abstract][Full Text] [Related]
20. Molecular Docking and Molecular Dynamics Studies to Identify Potential OXA-10 Extended Spectrum β-Lactamase Non-hydrolysing Inhibitors for Pseudomonas aeruginosa.
Malathi K; Ramaiah S
Cell Biochem Biophys; 2016 Jun; 74(2):141-55. PubMed ID: 27234361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
